Jarvik 2015 heart pump study for children with severe heart failure
Part of Heart & circulation clinical trials.
This study tests a new type of heart pump (the Jarvik 2015) for children with severe heart failure who are waiting for a heart transplant. The pump is designed to help the heart pump blood to the body until a donor heart becomes available.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child's weight must be between 8 and 30 kilograms (about 18 to 66 pounds).
- Your child must have severe heart failure (Class IV) that doesn't get better with medicines, and they need a mechanical heart pump to keep them alive until a transplant.
- Your child's heart must have two working pumping chambers (a 'two-ventricle' heart), not a single ventricle or certain complex heart defects.
- Your child must be on the waiting list for a heart transplant, or be eligible to be listed.
- Your child must not have severe problems with the right side of the heart, a serious heart rhythm issue, or other major organ failure (kidney, liver, lungs) that would make the pump unsafe.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new left ventricular assist device (LVAD) for people with advanced heart failure who are not responding to standard treatments and are eligible for a heart transplant. The pump helps the heart circulate blood.
This trial tests a left ventricular assist system (a mechanical heart pump for the left side of the heart) in people with very severe heart failure. It may help people who are too sick or not improving despite best available medical treatment.
This trial tests a new heart pump (BrioVAD) for people with very advanced heart failure. It aims to help those who are not getting better with standard treatments or who need extra support like IV medicines or a balloon pump.
This trial is evaluating a new temporary heart pump called CorVad for people who develop severe right heart failure shortly after heart surgery, a heart attack, or a heart transplant. The pump is designed to help the right side of the heart pump blood when medications are not enough.
This study tests whether using a temporary heart pump called Impella 5.5 can help strengthen a very weak and enlarged heart (dilated cardiomyopathy) in people who are waiting for a heart transplant. If you qualify, the pump is placed to support your heart temporarily, and the research team will check how your heart responds.
This trial is testing a temporary heart pump device that helps your heart pump blood when it's too weak to do its job. It's for people who have severe heart failure (cardiogenic shock) despite getting powerful medications to keep their heart working.
Hear when a new Heart Failure With Reduced Ejection Fraction trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.